On the epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in the adult population of Russia

Objective: to assess the trends in overall incidence and the distribution of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (AAV) in the adult population in federal district and across the Russian Federation during 2022–2023, based on data from the Nasonova Research Institute of Rheumatology.
Material and methods. The study is based on data collected via a federal-level inquiry addressed to regional healthcare departments concerning the organization of care and drug provision for patients with AAV in 2022–2023. The responses were qualitatively and quantitatively analyzed by experts from the N.A. Semashko National Research Institute of Public Health (Semashko NRIPH). Additionally, a retrospective single-center study was conducted involving adult patients (≥18 years) with AAV who received outpatient or inpatient care at the V.A. Nasonova Research Institute of Rheumatology (Nasonova RIR) from September 1, 2020, to October 1, 2024, with data obtained from the “Interin” system. Incidence was analyzed in absolute (the total number of registered patients aged ≥18) numbers and relative numbers (per 100,000 adult population) across Russia, in eight federal districts, and three climate/geography-based regions (Northern, Central, Southern). The frequency of antemortem kidney and/or nasal mucosa biopsy for diagnosis of AAV was also assessed.
Results and discussion. According to Semashko NRIPH, a total of 1,785 AAV patients were identified during 2022–2023. The national incidence of granulomatosis with polyangiitis (GPA) ranged from 2.63 to 1.86 per 100,000, microscopic polyangiitis (MPA) from 0.79 to 1.11, and eosinophilic granulomatosis with polyangiitis (EGPA) from 1.16 to 0.98. The greatest incidence and maximal rate of decrease was seen in GPA (-29.28%) and EGPA (-15.52%), while MPA showed a maximal increase in incidence (+40.51%) in the Northern region. Substantial differences were noted across federal districts.
Based on data from the Nasonova RIR, AAV was confirmed in 506 patients, most of whom were women (63%) from the Central region (p<0.001), with a gender gradient by region. Among 67 (13.2%) ANCA-negative patients with atypical presentations, kidney biopsy was more commonly performed (71.6%) than nasal mucosa biopsy (28.3%), p<0.001.
Conclusion. This pilot study revealed regional and gender-related differences in AAV incidence across Russia, as well as low frequency of antemortem biopsy of kidney/nasal mucosa. These findings warrant further in-depth investigation into factors influencing these trends.

1. White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev. 2023 Jan;22(1):103219. doi: 10.1016/j.autrev.2022.103219.

2. Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764.

3. Robson JC, Grayson PC, Ponte C, et al. 2022 American College of Rheumatology/ European Alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Arthritis Rheumatol. 2022 Mar;74(3):393-399. doi: 10.1002/art.41986. Epub 2022 Feb 2.

4. Suppiah R, Robson JC, Grayson PC, et al; DCVAS Study Group. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheum. 2022 Mar;74(3):400-406. doi: 10.1002/art.41983. Epub 2022 Feb 2.

5. Chevet B, Cornec D, Moura MC, et al. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice. Rheumatology (Oxford). 2023 May 2; 62(5):1787-1803. doi: 10.1093/rheumatology/keac623.

6. Watts RA, Mahr A, Mohammad AJ, et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015 Apr:30 Suppl 1:i14-22. doi: 10.1093/ndt/gfv022.

7. Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020 Jan;75(1):124-137. doi: 10.1053/j.ajkd.2019.04.031. Epub 2019 Jul 26.

8. Berti A, Caporali R, Montecucco C, et al. Aging in primary systemic vasculitis: implications for diagnosis, clinical manifestations, and management. Drugs Aging. 2019 Jan; 36(1):53-63. doi: 10.1007/s40266-018-0617-4.

9. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a tenyear study in the United Kingdom. Arthritis Rheum. 2000 Feb;43(2):414-9. doi: 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0.

10. Rathmann J, Segelmark M, Englund M, Mohammad AJ. Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study. RMD Open. 2023 Mar;9(1):e002949. doi: 10.1136/rmdopen-2022-002949.

11. Jariwala M, Laxer RM. Childhood GPA, EGPA, and MPA. Clin Immunol. 2020 Feb: 211:108325. doi: 10.1016/j.clim.2019.108325. Epub 2019 Dec 11.

12. Redondo-Rodriguez R, Mena-Vazquez N, Cabezas-Lucena AM, et al. Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J Clin Med. 2022 May 4;11(9):2573. doi: 10.3390/jcm11092573.

13. Mohammad AJ. An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford). 2020 May 1;59 (Suppl 3):iii42-iii50. doi: 10.1093/rheumatology/keaa089

14. Galushko EA, Nasonov EL. Prevalence of rheumatic diseases in Russia. Al'manakh klinicheskoi meditsiny. 2018;46(1):32-39. (In Russ.).

15. Shilkina NP, Dryazhenkova IV. On the epidemiology of systemic vasculitis. In: Collection of abstracts of the II All-Russian Conference of Rheumatologists "Social aspects of rheumatic diseases". Voronezh; 2006. P. 124.

16. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990 Aug; 33(8):1101-7. doi: 10.1002/art.1780330807.

17. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990 Aug;33(8):1094- 100. doi: 10.1002/art.1780330806.

18. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.

19. https://www.garshinka.ru/faq/kakoimoi-region-uznyi-centralnyi-ili-severnyi

20. https://ru.ruwiki.ru/wiki/Федеральные_округа_Российской_Федерации

21. https://ru.m.wikipedia.org/wiki/%D0%9D%D0%B0%D1%81%D0%B5%D0%BB%D0%B5%D0%BD%D0%B8%D0%B5_%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D0%B8

22. Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M. Incidence of Wegener’s granulomatosis in Finland 1981–2000. Clin Exp Rheumatol. 2008 May-Jun;26 (3 Suppl 49):S81-5.

23. Pearce FA, Grainge MJ, Lanyon PC, et al. The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK. Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 Apr 1;56(4):589-596. doi: 10.1093/rheumatology/kew413.

24. Naidu GSRSNK, Misra DP, Rathi M, Sharma A. Is granulomatosis with polyangiitis in Asia different from the West? Int J Rheum Dis. 2019 Jan:22 Suppl 1:90-94. doi: 10.1111/1756-185X.13398.

25. Li J, Cui Z, Long JY et al. The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China. Arthritis Res Ther. 2018 Oct 4;20(1):226. doi: 10.1186/s13075-018-1708-7.

26. Sacri AS, Chambaraud Т, Ranchin В, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant. 2015 Apr:30 Suppl 1:i104-12. doi: 10.1093/ndt/gfv011. Epub 2015 Feb 12.

27. Mossberg M, Segelmark M, Kahn R, et al. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Scand J Rheumatol. 2018 Jul;47(4):295-302. doi: 10.1080/03009742.2017.1412497. Epub 2018 Feb 7.

28. Pearce FA, Lanyon PC, Grainge MJ, et al. Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population. Rheumatology (Oxford). 2016 Sep;55(9):1656-63. doi: 10.1093/rheumatology/kew232. Epub 2016 Jun 5.

29. Pamuk ÖN, Dönmez S, Calayir GB, Pamuk GE. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol. 2016 Aug;35(8):2063-2071. doi: 10.1007/s10067-016-3232-y. Epub 2016 Mar 18.

30. Berti A, Cornec D, Crowson CS, et al. The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study. Arthritis Rheumatol. 2017 Dec;69(12):2338-2350. doi: 10.1002/art.40313.

31. Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.

32. Ozguler Y, Esatoglu SN, Hatemi G. Epidemiology of systemic vasculitis. Curr Opin Rheumatol. 2024 Jan 1;36(1):21-26. doi: 10.1097/BOR.0000000000000983. Epub 2023 Oct 5.

33. Yamagata K, Usui J, Sugiyama H, et al. Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey. Clin Exp Nephrol. 2013 Oct;17(5):646-649. doi: 10.1007/s10157-012-0740-1

34. O'Donnell JL, Stevanovic VR, Frampton C, et al. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J. 2007 Apr; 37(4):242-6. doi: 10.1111/j.1445-5994.2006.01297.x.

35. Gibson A, Stamp LK, Chapman PT, O'Donnell JL. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford). 2006 May;45(5):624-8. doi: 10.1093/rheumatology/kei259.

36. Stamp LK, Chapman PT, Francis J, et al.Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand. Arthritis Res Ther. 2015 Nov 24;17:333. doi: 10.1186/s13075-015-0852-6.

37. Sharma A, Naidu GSRSNK, Rathi M, et al. Clinical features and long term outcomes of 105 granulomatosis with polyangiitis patients: a single centre experience from north India. Int J Rheum Dis. 2018 Jan;21(1): 278-284. doi: 10.1111/1756-185X.13071.

38. Kim HW, Kim JW, Im CH, et al. The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener's): a retrospective study of 45 patients in Korea. Mod Rheumatol. 2013 Sep;23(5):864-71. doi: 10.1007/s10165-012-0754-2. Epub 2012 Sep 15.

39. Ono N, Niiro H, Ueda A, et al. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-centre study in Japan. Rheumatol Int. 2015 Mar;35(3):555-9. doi: 10.1007/s00296-014-3106-z.

40. Sharma A, Lakshman A, Nampoothiri RV, et al. Pulmonary and Ear, Nose and Throat (ENT) involvement in ANCA-associated vasculitis at diagnosis – Experience from a tertiary care centre in North India. J Assoc Physicians India. 2017 Oct;65(12):40-47.

41. Yamagata K, Usui J, Sugiyama H, et al. Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey. Clin Exp Nephrol. 2013 Oct;17(5):646-649. doi: 10.1007/s10157-012-0740-1.

42. Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011 Oct;50(10):1916-20. doi: 10.1093/rheumatology/ker205. Epub 2011 Jul 28.

43. Knopf A, Chaker A, Stark T, et al. Clinical aspects of granulomatosis with polyangiitis affecting the head and neck. Eur Arch Otorhinolaryngol. 2015 Jan;272:185-93. doi: 10.1007/s00405-014-2973-y